Divi's Labs elevates Nimmagadda Venkata Anirudh as President (Nutraceuticals)

He joined Divi's Laboratories Limited in the year 2014 as the Relationship Manager for all the customers in the US & Canada region. Post his role as Relationship Manager - USA, he was tasked with handling the Indian customers manufacturing the finished dose formulations for the global markets along with the MNC customers that Divi's was working with on the generic side of the business.

In September 2022, he was promoted as Head of Nutraceuticals. In his role, he was assigned to maximize the sales potential for each of the nutraceutical ingredients, identification of new ingredients to the Company's portfolio, improve operational efficiencies, optimise raw material procurement and oversee the subsidiaries operations in USA and Switzerland.

Read also: Divi's Labs signs agreement with global pharmaceutical company

Established in the year 1990, Divi’s is a manufacturer of Active Pharmaceutical Ingredients offering products to over 95 countries. Divi’s manufactures Generic APIs, Nutraceutical Ingredients and offers Custom Synthesis of APIs to Big Pharma. The Company currently operates two manufacturing locations that are compliant with global regulatory standards and capable of producing annual requirements ranging from 10’s of kilos to 1000’s of tons. It complies with cGMP guidelines for both the manufacturing units, having been inspected numerous times by FDA, EU GMP , HEALTH CANADA, TGA, ANVISA , COFEPRIS, PMDA and MFDS health authorities.